Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02746458 · ClinicalTrials.gov registry record · NA
Rehabilitation Enhanced by Partial Arterial Inflow Restrictions
A NA study of Closed Femur Fracture, sponsored by Major Extremity Trauma Research Consortium.
- Active
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 8
- Study locations
NCT02746458: Active NA study of Closed Femur Fracture, sponsored by Major Extremity Trauma Research Consortium.
NCT02746458 is a NA study of Closed Femur Fracture that is active but no longer recruiting, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02746458, a NA study of Closed Femur Fracture, is active but no longer recruiting, sponsored by Major Extremity Trauma Research Consortium.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 8
- Study locations
Study Summary
The Rehabilitation Enhanced by Partial Arterial Inflow Restriction (REPAIR) Study will be conducted in a patient population of individuals recovering from a traumatic diaphyseal fracture of the femur. Although the intervention can be used for any patient with muscle weakness following trauma, the persistent thigh weakness that follows a femur fracture provides a perfect model for evaluating the effectiveness of the REPAIR protocol.
Primary Outcome
Five muscle actions were tested using a handheld dynamometer with the patient in the seated (knee extension, hip flexion), supine (hip abduction), and prone (knee flexion, hip extension) position.
Conditions Studied
Interventions
- OTHER Blood Flow Restriction
- DEVICE Delfi PTSII Tourniquet System
Study Locations (8)
Maryland
- University of Maryland Medical Center - Baltimore
- Walter Reed National Military Medical Center - Bethesda
Texas
- University of Texas Health Science Center at Houston - Houston
- San Antonio Military Medical Center - San Antonio
Indiana
- Methodist Hospital - Indianapolis
Missouri
- Barnes Jewish Hospital - St Louis
North Carolina
- Carolinas Medical Center - Charlotte
Ohio
- MetroHealth - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
What the registry record for NCT02746458 still lists
NCT02746458 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Closed Femur Fracture appearing as the primary indexed condition, and to 2 interventions - of which Blood Flow Restriction is the first listed.
NCT02746458 lists 8 locations in 6 states (Maryland, Texas, Indiana).
Frequently Asked Questions
What is clinical trial NCT02746458 about?
NCT02746458 is a clinical study titled "Rehabilitation Enhanced by Partial Arterial Inflow Restrictions". The Rehabilitation Enhanced by Partial Arterial Inflow Restriction (REPAIR) Study will be conducted in a patient population of individuals recovering from a traumatic diaphyseal fracture of the femur. Although the intervention can be used for any patient with muscle weakness following trauma, the pe...
What is the current status of trial NCT02746458?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2016-04-01. Estimated completion is 2024-08-01.
What conditions does trial NCT02746458 study?
This clinical trial studies the following conditions: Closed Femur Fracture.
What interventions are being tested in trial NCT02746458?
The interventions under investigation include: Blood Flow Restriction (OTHER), Delfi PTSII Tourniquet System (DEVICE).
Who is sponsoring clinical trial NCT02746458?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02746458 being conducted?
This trial has 8 study locations across Indiana, Maryland, Missouri, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02746458's enrollment target sits among peer trials
250 410th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI